Zou Xueqing, Koh Gene Ching Chiek, Nanda Arjun Scott, Degasperi Andrea, Urgo Katie, Roumeliotis Theodoros I, Agu Chukwuma A, Badja Cherif, Momen Sophie, Young Jamie, Amarante Tauanne Dias, Side Lucy, Brice Glen, Perez-Alonso Vanesa, Rueda Daniel, Gomez Celine, Bushell Wendy, Harris Rebecca, Choudhary Jyoti S, Jiricny Josef, Skarnes William C, Nik-Zainal Serena
Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
MRC Cancer Unit, University of Cambridge, Cambridge, UK.
Nat Cancer. 2021 Jun;2(6):643-657. doi: 10.1038/s43018-021-00200-0. Epub 2021 Apr 26.
Mutational signatures are imprints of pathophysiological processes arising through tumorigenesis. We generated isogenic CRISPR-Cas9 knockouts (Δ) of 43 genes in human induced pluripotent stem cells, cultured them in the absence of added DNA damage, and performed whole-genome sequencing of 173 subclones. Δ Δ Δ Δ Δ Δ Δ Δ and Δ produced marked mutational signatures indicative of being critical mitigators of endogenous DNA modifications. Detailed analyses revealed mutational mechanistic insights, including how 8-oxo-dG elimination is sequence-context-specific while uracil clearance is sequence-context-independent. Mismatch repair (MMR) deficiency signatures are engendered by oxidative damage (C>A transversions), differential misincorporation by replicative polymerases (T>C and C>T transitions), and we propose a 'reverse template slippage' model for T>A transversions. Δ Δ and Δ signatures were similar to each other but distinct from Δ. Finally, we developed a classifier, MMRDetect, where application to 7,695 WGS cancers showed enhanced detection of MMR-deficient tumors, with implications for responsiveness to immunotherapies.
突变特征是肿瘤发生过程中产生的病理生理过程的印记。我们在人类诱导多能干细胞中生成了43个基因的同基因CRISPR-Cas9敲除(Δ),在不添加DNA损伤的情况下培养它们,并对173个亚克隆进行了全基因组测序。Δ Δ Δ Δ Δ Δ Δ Δ和Δ产生了明显的突变特征,表明它们是内源性DNA修饰的关键缓解因子。详细分析揭示了突变机制的见解,包括8-氧代-dG消除如何具有序列上下文特异性,而尿嘧啶清除则与序列上下文无关。错配修复(MMR)缺陷特征由氧化损伤(C>A颠换)、复制性聚合酶的差异错配掺入(T>C和C>T转换)产生,并且我们提出了一个T>A颠换的“反向模板滑动”模型。Δ Δ和Δ特征彼此相似,但与Δ不同。最后,我们开发了一个分类器MMRDetect,将其应用于7695个全基因组测序癌症样本时,显示出对MMR缺陷肿瘤的检测增强,这对免疫治疗的反应性具有影响。